DKCM
BMY.RT
Davidson Kempner Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-5,249,241
| Closed | -$3.62M | – | 568 |
|
|
2020
Q4 | $3.62M | Sell |
5,249,241
-6,959,850
| -57% | -$4.8M | 0.04% | 203 |
|
|
2020
Q3 | $27.5M | Buy |
12,209,091
+2,914,489
| +31% | +$6.56M | 0.39% | 60 |
|
|
2020
Q2 | $33.3M | Buy |
9,294,602
+5,678,683
| +157% | +$20.3M | 0.8% | 31 |
|
|
2020
Q1 | $13.7M | Sell |
3,615,919
-58,539
| -2% | -$222K | 0.37% | 61 |
|
|
2019
Q4 | $11.1M | Buy |
+3,674,458
| New | +$11.1M | 0.25% | 73 |
|